glp-1 obesity drug market news today The Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs Dozens of new obesity drugs
Description
In the same 2025 study by Qeadan and colleagues, individuals with a history of opioid use disorder (n=503,747) prescribed GLP-1 medications had about a 40% lower rate of opioid overdose events during the 2-year follow-up period (Qeadan et al., 2025)
Reid IR, Baldock PA, Cornish J
"Well, how do we get them in our body
Magkos F, Hjorth MF, Astrup A
Did they drop coverage for everyone
doi: 10.1152/ajpendo.00330.2023 [DOI] [PMC free article] [PubMed] [Google Scholar] 170
